Thoracic Endovascular Aortic Repair-indications and Evidence

Thoracic aortic surgery: An overview of 40 years clinical practice

“…13,14 However, long-term results of TEVAR therapy are still unknown, and randomized trials comparing open surgery and TEVAR are lacking, making definitive conclusions on the merits of TEVAR impossible. 15 Over time, early mortality decreased significantly from >50% early in the series in all 4 patients groups to 15% for acute type A dissections, 1.9% for other ascending aortic and arch pathology, 0% for descending aortic aneurysms, and 10.5% for thoracoabdominal aneurysms in the most recent era of 2007 to 2011. These recent early mortality rates are in line with other published series and outline the safety of thoracic aortic surgery in the current era.…”

Combined Thoracic Endovascular Aortic Repair and Neurosurgical Intervention for Injury Due to Posterior Spine Surgery

“…Thoracic endovascular aortic repair (TEVAR), first described by Dake in 1994, currently represents a first option strategy for many patients with a thoracic aortic pathology . The use of TEVAR in aortic trauma has contributed to a reduction of both mortality and morbidity mainly due to the incidence of postoperative respiratory failure and paraplegia seen after open aortic surgery …”

“…[21][22][23][24][25][26] The use of TEVAR in aortic trauma has contributed to a reduction of both mortality and morbidity mainly due to the incidence of postoperative respiratory failure and paraplegia seen after open aortic surgery. [27][28][29][30][31][32][33][34][35] Thoracic endografting allows the repair of focal aortic perforations with a low incidence of endoleak or graft migration that would need a secondary intervention. This is probably due to the usually normal anatomical features of the injured aorta above and below the perforation, unlike degenerative aneurysmatic disease.…”

An Unusual Complication of Surgery for Type A Dissection Treated by Thoracic Endovascular Aortic Repair

“…Indeed, since its introduction more than a decade ago, TEVAR has shown promising results for patients with various thoracic aortic diseases [4]. These include unstable acute type B aortic dissection, chronic type B aortic dissection, and type B dissection with retrograde extension into the ascending aorta [5]. The concept of this procedure was directed toward sealing the proximal intimal tear, redirecting the flow into the true lumen, and promoting depressurization and thrombosis of the false lumen.…”